Aktie 1783 MAXIGEN BIOTECH INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Maxigen Biotech Inc.

Aktien

1783

TW0001783009

1783

Schlusskurs Taiwan S.E.
Andere Börsenplätze
 00:00:00 21.05.2024 		% 5 Tage % 1. Jan.
43,4 TWD -0,91 % Intraday Chart für Maxigen Biotech Inc. +0,46 % -10,33 %
06.05. Maxigen Biotech Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
21.03. Maxigen Biotech Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Maxigen Biotech Inc.(TWSE:1783) added to S&P Global BMI Index
Maxigen Biotech Inc. Declares Dividend, Payable on October 12, 2023
Maxigen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Maxigen Biotech Inc. Announces Cash Dividend for the Period from January 1, 2022 to December 31, 2022
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Maxigen Biotech Inc. Announces Executive Changes
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended December 2022
Maxigen Biotech Inc. Announces Resignation of You Wan-How as Financial Officer and Accounting Officer
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended November 2022
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended October 2022
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Maxigen Biotech Inc. Reports Consolidated Revenue Results for the Month and Year-To-Date Ended September 2022
Maxigen Biotech : Monthly revenue report, July 2022
Maxigen Biotech Inc. Reports Consolidated Revenue Results for the Month and Year-to-Date Ended July 2022
Maxigen Biotech : Board of Directors' Resolution for the change of the chief internal auditor
Maxigen Biotech : Board of Directors approved the financial reports for the second quarter of 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 1783 Aktie
  4. Nachrichten Maxigen Biotech Inc.
  5. Andere Sprachen